FR2737661B1 - PHARMACEUTICAL COMPOSITION IN THE FORM OF TABLETS COMPRISING PILOCARPINE HYDROCHLORIDE - Google Patents

PHARMACEUTICAL COMPOSITION IN THE FORM OF TABLETS COMPRISING PILOCARPINE HYDROCHLORIDE

Info

Publication number
FR2737661B1
FR2737661B1 FR9509624A FR9509624A FR2737661B1 FR 2737661 B1 FR2737661 B1 FR 2737661B1 FR 9509624 A FR9509624 A FR 9509624A FR 9509624 A FR9509624 A FR 9509624A FR 2737661 B1 FR2737661 B1 FR 2737661B1
Authority
FR
France
Prior art keywords
tablets
pharmaceutical composition
pilocarpine hydrochloride
pilocarpine
hydrochloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9509624A
Other languages
French (fr)
Other versions
FR2737661A1 (en
Inventor
Charles C Muscoplat
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MGI Pharma Inc
Original Assignee
MGI Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MGI Pharma Inc filed Critical MGI Pharma Inc
Priority to FR9509624A priority Critical patent/FR2737661B1/en
Publication of FR2737661A1 publication Critical patent/FR2737661A1/en
Application granted granted Critical
Publication of FR2737661B1 publication Critical patent/FR2737661B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR9509624A 1995-08-08 1995-08-08 PHARMACEUTICAL COMPOSITION IN THE FORM OF TABLETS COMPRISING PILOCARPINE HYDROCHLORIDE Expired - Lifetime FR2737661B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR9509624A FR2737661B1 (en) 1995-08-08 1995-08-08 PHARMACEUTICAL COMPOSITION IN THE FORM OF TABLETS COMPRISING PILOCARPINE HYDROCHLORIDE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9509624A FR2737661B1 (en) 1995-08-08 1995-08-08 PHARMACEUTICAL COMPOSITION IN THE FORM OF TABLETS COMPRISING PILOCARPINE HYDROCHLORIDE

Publications (2)

Publication Number Publication Date
FR2737661A1 FR2737661A1 (en) 1997-02-14
FR2737661B1 true FR2737661B1 (en) 1997-10-31

Family

ID=9481793

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9509624A Expired - Lifetime FR2737661B1 (en) 1995-08-08 1995-08-08 PHARMACEUTICAL COMPOSITION IN THE FORM OF TABLETS COMPRISING PILOCARPINE HYDROCHLORIDE

Country Status (1)

Country Link
FR (1) FR2737661B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2864901B1 (en) * 2004-01-09 2007-10-05 Philippe Perovitch COMPOSITION FOR THE TREATMENT IN CONTACT WITH HYPOSIALIES, INCLUDING PILOCARPINE AND MULTIPLE EFFECTS

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1223150B (en) * 1987-11-18 1990-09-12 Ubaldo Conte TABLET FOR OPHTHALMIC USE AND CONTROLLED RELEASE OF THE ACTIVE SUBSTANCE
US5021053A (en) * 1989-07-14 1991-06-04 Alza Corporation Oral osmotic device with hydrogel driving member
IT1250421B (en) * 1991-05-30 1995-04-07 Recordati Chem Pharm CONTROLLED RELEASE PHARMACEUTICAL COMPOSITION WITH BIO-ADHESIVE PROPERTIES.
CA2093282C (en) * 1992-05-04 1999-01-12 Tibor Sipos Intraoral medicament-releasing device
WO1994001108A1 (en) * 1992-07-02 1994-01-20 Theratech, Inc. Controlled release pilocarpine delivery system

Also Published As

Publication number Publication date
FR2737661A1 (en) 1997-02-14

Similar Documents

Publication Publication Date Title
FR2732223B1 (en) PHARMACEUTICAL COMPOSITION FOR TRANSDERMAL ADMINISTRATION
NO20021172D0 (en) Pharmaceutical composition
FR2734483B1 (en) PHARMACEUTICAL ADMINISTRATION FORM COMPRISING OXYBUTYNIN
IL117237A (en) Pharmaceutical compositions of piperidinoalkanol compounds in solid unit dosage form
NO961136D0 (en) Pharmaceutical formulation basis for nano-suspensions
HK1001860A1 (en) I-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients
ZA965866B (en) 6-Dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
DE69525148D1 (en) PHARMACEUTICAL FORMULATION
IL123986A0 (en) Antithombotic agents process for their preparation and pharmaceutical compositions comprising them
MA26842A1 (en) BICYCLIC AMINO ACIDS AS PHARMACEUTICAL AGENTS
DE69618587T2 (en) CHINAZOLINE AND PHARMACEUTICAL COMPOSITIONS
BR9506119A (en) Pharmaceutical composition and unit pharmaceutical dosage form
EP0727217A3 (en) Pharmaceutical composition containing god-type ellagitannin as active ingredient
NO981008D0 (en) Pharmaceutical formulation
FI955311A0 (en) Pharmaceutical composition base
FR2792836B3 (en) PHARMACEUTICAL COMPOSITION IN UNIT FORM CONTAINING ASPIRIN AND CLOPIDOGREL HYDROGENOSULFATE
IL122705A (en) 2-(4-Susbstituted)-benzylamino-2-methyl-propanamide derivatives their preparation and pharmaceutical compositions containing them
IL123927A (en) Propanolamine derivatives processes for their preparation and pharmaceutical composition comprising them
HUP9700005A3 (en) 2-ureido-benzamide derivatives and pharmaceutical compositions containing them as active agent
FR2760639B1 (en) MINERALO-VITAMIN THERAPEUTIC ASSOCIATION IN THE FORM OF A UNITABLE ORAL LIQUID PREPARATION
EG23781A (en) Pharmaceutical composition containing tiagabine hydrochloride and the process for its preparation
HUP9903684A3 (en) Use of olanzapine for the preparation of pharmaceutical compositions treating depression
DE69614407D1 (en) PHARMACEUTICAL COMPOSITIONS
LV11727A (en) Pharmaceutical composition
FI973229A (en) New pharmaceutical composition

Legal Events

Date Code Title Description
TP Transmission of property